RxTrials Named to Shortlist for 2012 Vaccine Industry Excellence Award

ELLICOT CITY, Md., March 13, 2012 /PRNewswire/ -- RxTrials, Inc., has earned a spot on this year's shortlist for the 5th Annual Vaccine Industry Excellence (ViE) Awards, in the category of Best Clinical Trial Network. The ViE awards, sponsored by Novartis Vaccines and Diagnostics, were created to recognize the accomplishments and contributions of companies and individuals in the vaccine industry over the previous 12 months.

RxTrials was founded in 1994 by Christine Pierre, RN, to provide expertise in clinical study management through a network of premiere research sites. Through partnerships with more than 100 top study sponsors and CROs, RxTrials has conducted more than 1,000 studies helping to bring new vaccines, drugs and medical devices to market.

The ViE Award nominees are voted on by those in the global vaccine industry and also judged by a panel of representatives from pharma, biotech, academia, government, non-governmental organizations (NGOs), and public health. Winners are announced at the annual ViE Awards dinner and ceremony, taking place this year on April 11 during the World Vaccine Congress in Washington, D.C.

"It is an incredible honor to be considered among the top site networks for this highly regarded award," said Pierre. "Just to be on the shortlist, in such excellent company, means our peers understand and recognize the dedication we have to supporting the vital work being done in the vaccine industry."

RxTrials and ViE Awards

The category of Best Clinical Trial Network recognizes RxTrials service to vaccine study sponsors and CROs. Criteria used to judge this category include:

  • Range and reach of the networks' independently-owned, geographically diverse research sites specializing in activemulti-therapeutic vaccine trials.
  • Ability to engage multiple network members in multi-sized studies requiring diverse multiple sites/populations.
  • Services that maximize economies of scale, consistency and study efficiencies.
  • Mentoring capabilities to support timely goal attainment, study completion and related efficiencies, cost containment measures, consistent and accurate data collection, validation and enrollment/retention processes.
  • Forging of ongoing partnerships for future study participation opportunities.

More information about RxTrials can be found at www.rxtrialsinc.com

Details about the ViE Awards is available at the World Vaccine Congress website: www.terrapinn.com/conference/world-vaccine-congress-washington/index.stm

SOURCE RxTrials Institute

MORE ON THIS TOPIC